Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
G&E Herbal Biotechnology CoROCO:4911 +0.43%63 Quick Ratio is 9.55 as of Dec. 2025, which is 11% above its 10-year median of 8.62. GuruFocus rates ROCO:4911 with a GF Score™ of 63/100 and a GF Value™ of NT$86.94 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 1,412 Biotechnology companies, G&E Herbal Biotechnology Co ranks better than 77.41% on this metric.
G&E Herbal Biotechnology Co has a quick ratio of 9.55. It generally indicates good short-term financial strength.
The historical rank and industry rank for G&E Herbal Biotechnology Co's Quick Ratio or its related term are showing as below:
ROCO:4911'
s Quick Ratio Range Over the Past 10 Years
Min: 2.27 Med: 8.62 Max: 15.4
Current: 9.55
During the past 13 years, G&E Herbal Biotechnology Co's highest Quick Ratio was 15.40. The lowest was 2.27. And the median was 8.62.
ROCO:4911's Quick Ratio is ranked better than 77.41% of 1412
companies
in the Biotechnology industry
Industry Median: 3.595
vs ROCO:4911: 9.55
G&E Herbal Biotechnology Co (ROCO:4911) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
G&E Herbal Biotechnology Co Quick Ratio Related Terms
G&E Herbal Biotechnology Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4911 vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, G&E Herbal Biotechnology Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
G&E Herbal Biotechnology Co Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, G&E Herbal Biotechnology Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where G&E Herbal Biotechnology Co's Quick Ratio falls into.
G&E Herbal Biotechnology Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
G&E Herbal Biotechnology Co (ROCO:4911) has a Quick Ratio of 9.55 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on G&E Herbal Biotechnology Co and its competitors. This is 11% above median its historical median of 8.62. Over the past decade, G&E Herbal Biotechnology Co's Quick Ratio has ranged from 2.27 to 15.40. According to the industry distribution chart, G&E Herbal Biotechnology Co ranks #319 out of 1412 companies in the Biotechnology industry, placing it in the top 22.6%.
Is G&E Herbal Biotechnology Co's Quick Ratio too high?
G&E Herbal Biotechnology Co's current Quick Ratio of 9.55 is 11% above median its 10-year median of 8.62. Over the past 10 years, this metric has ranged from a low of 2.27 to a high of 15.40. The Biotechnology industry median Quick Ratio is 3.60. G&E Herbal Biotechnology Co's value of 9.55 is 165.6% above this industry median. Based on the distribution chart, G&E Herbal Biotechnology Co ranks #319 out of 1412 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, G&E Herbal Biotechnology Co has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does G&E Herbal Biotechnology Co's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, G&E Herbal Biotechnology Co ranks #319 out of 1412 companies for Quick Ratio. This places G&E Herbal Biotechnology Co in the top 23% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 3.60. G&E Herbal Biotechnology Co's value of 9.55 is 165.6% above this benchmark. Historically, G&E Herbal Biotechnology Co's own Quick Ratio has ranged from 2.27 to 15.40 over the past decade. While the company's 10-year median is 8.62 vs. the industry median of 3.60, G&E Herbal Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,412 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. G&E Herbal Biotechnology Co's current Quick Ratio of 9.55 is 165.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on G&E Herbal Biotechnology Co and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. G&E Herbal Biotechnology Co's current Quick Ratio is 9.55, which is 11% above median its own 10-year median of 8.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is G&E Herbal Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, G&E Herbal Biotechnology Co (ROCO:4911) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$86.94, compared to a current price of NT$34.85 — trading 59.9% below its estimated fair value. The current Quick Ratio is 9.55, which is 11% above median its 10-year median of 8.62 and 165.6% above the Biotechnology industry median of 3.60. G&E Herbal Biotechnology Co's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For G&E Herbal Biotechnology Co (ROCO:4911), the current Quick Ratio is 9.55 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is G&E Herbal Biotechnology Co (ROCO:4911) Overvalued in 2026?
Based on GuruFocus' analysis, G&E Herbal Biotechnology Co stock appears to be undervalued.
The current stock price of NT$34.85 is trading 59.9% below its estimated GF Value™ of NT$86.94.
GuruFocus considers G&E Herbal Biotechnology Co to be Significantly Undervalued.
Key valuation signals for ROCO:4911:
Quick Ratio: 9.55 (11% above median its 10-year median of 8.62)
GF Value™: NT$86.94 vs. price of NT$34.85 (59.9% below fair value)
Industry Position: 165.6% above the Biotechnology median (#319 of 1412)
No single metric tells the full story. See the ROCO:4911 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
G&E Herbal Biotechnology Co Ltd is a Taiwan-based biopharmaceutical company. It specializes in the production of Western conventional drugs, Chinese traditional drugs, unclassified food, cosmetics, and health products. The company is focused on botanical extraction technology and products. Its products include botanical extract toner, total moisture conditioning cream, whitening clear cream, and firming essence cream.
63GF Score
Get the complete analysis for ROCO:4911
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4911 has been successfully added to your 
